✦ LIBER ✦

Management of the Relapsed/Refractory Myeloma Patient: Strategies Incorporating Lenalidomide

✍ Scribed by Paul Richardson

Book ID: 117821904
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 242 KB
Volume: 42
Category: Article
ISSN: 1532-8686
DOI: 10.1053/j.seminhematol.2005.10.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 2 trial of lenalidomide, bortezo

A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma

✍ Richardson, P. G.; Xie, W.; Jagannath, S.; Jakubowiak, A.; Lonial, S.; Raje, N. 📂 Article 📅 2014 🏛 American Society of Hematology 🌐 English ⚖ 510 KB

Lenalidomide is effective for extramedul

Lenalidomide is effective for extramedullary disease in relapsed or refractory multiple myeloma

✍ José M. Calvo-Villas; Adrián Alegre; Carmen Calle; Miguel T. Hernández; Ricarda 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Activity of Lenalidomide in Patients wit

Activity of Lenalidomide in Patients with Relapsed or Refractory Multiple Myeloma: Data from Phase III Studies

✍ Gibson, Tara Beers; Mariani, Sara; Jain, Vinay K. 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 849 KB

Efficacy of thalidomide-based therapy fo

Efficacy of thalidomide-based therapy following lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma

✍ Kukreti, Vishal; Masih-Khan, Esther; Young, Trieu; Chu, Chia-Min; Jiang, Haiyun; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Effects of Lenalidomide and Dexamethason

Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone

✍ Jesús F. San-Miguel; Meletios A. Dimopoulos; Edward A. Stadtmauer; S. Vincent Ra 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 208 KB

The addition of cyclophosphamide to lena

The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II study

✍ Stephen A. Schey; Gareth J. Morgan; Karthik Ramasamy; Beth Hazel; Dariusz Ladon; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB